Acarix
Scion-DTU, Diplomvej 376
Kongens Lyngby
DK-2800
Tel: 45-2777-1112
Website: http://www.acarix.com/
Email: info@acarix.com
About Acarix
Acarix A/S was established in 2009, and since 2010 investors SEED Capital (DK) and Sunstone Life Science Ventures (DK) have supported it towards market introduction. Acarix has attracted a highly-experienced management team who have held senior positions in international medical device companies - CEO Søren Rysholt Christiansen with ELOS Medtech, GN ReSound and Cook Medical.YEAR FOUNDED:
2009
LEADERSHIP:
CEO: Søren Rysholt Christiansen
JOBS:
Please click here for Acarix job opportunities.
PRODUCTS:
All Products
9 articles about Acarix
-
Acarix announces the initiation of the first US-based clinical workflow evaluation study
4/11/2024
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to collect real-world data to compare workflows between traditional stress tests and the CADScor System.
-
New Health Economic Analysis Presented at ACC Highlights the Acarix CADScor System's Cost-Effectiveness
4/8/2024
Acarix is pleased to announce the results from a 2024 American College of Cardiology poster presentation by Suzanne Baron, MD, MSc, Director of Interventional Cardiology Research, Massachusetts General Hospital and Faculty at The Baim Institute for Clinical Research, to assess the cost-utility of the CADScor System for the evaluation of coronary artery disease in a low-risk patient population presenting to the Emergency Department with chest pain.
-
Acarix Strengthens U.S. Team with Three Key Advisors
2/15/2024
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the appointment of three new advisors to its team.
-
Acarix appoints Aamir Mahmood as new CEO
2/1/2024
The Board of Acarix AB (publ) announces the immediate appointment of Aamir Mahmood as its new CEO, effective February 1.
-
DAN-NICADII Study to Expand the Applicability of the Non-Invasive Acarix CADScor System for Rapid Ruling Out Coronary Artery Disease
1/9/2018
The results from the extensive study are expected to be available early 2020.
-
Acarix Receives First German Commercial Order For CADScor System For Early Detection Of Coronary Artery Disease From Private Cardiology Clinic In Berlin
7/5/2017
-
Acarix Receives First Commercial Order For CADScor System For Early Detection Of Coronary Artery Disease From Danish Hospital
6/14/2017
-
Acarix Awarded Danish Design Award 2017 For Its Innovative Heart Disease Testing Device; CADScor System
5/10/2017
-
Acarix CADScor System Multi-Center Trial Results Confirm Previous Preliminary Results Ruling Out CAD With 97% Negative Predictive Value
3/17/2017